Yani Zinis, DO
Physical Medicine & Rehabilitation · Denver, CONPI 1114028495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 25.4% of the total.
Across 33 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$181
- AbbVie$82
- Ossur Americas, Inc.$63
- Fidia Pharma USA Inc.$62
- Saol Therapeutics Inc.$57
- Amgen$53
- plus $214 from 9 others
What the payments were for
- Food & beverage$713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 4 | $181 |
| AbbVie | 3 | $82 |
| Ossur Americas, Inc. | 4 | $63 |
| Fidia Pharma USA Inc. | 5 | $62 |
| Saol Therapeutics Inc. | 1 | $57 |
| Amgen | 4 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Bioventus LLC | 2 | $38 |
| IBSA Pharma Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Pfizer | 1 | $16 |
| Vertex | 1 | $15 |
| Orthogenrx Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$148
How this compares
$713 in reported general payments places this provider in the 70th percentile of 199 physical medicine & rehabilitation providers in Colorado.
See all physical medicine & rehabilitation providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 239 | $7,214 |
| OxycontinOxycodone Hcl | 23 | $7,006 |
| Oxycodone Hcl | 302 | $6,737 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $5,078 |
| Pregabalin | 129 | $4,011 |
| Buprenorphine | 12 | $2,009 |
| Tramadol Hcl | 248 | $1,831 |
| Modafinil | 13 | $1,516 |
| Methylprednisolone | 190 | $1,456 |
| Gabapentin | 99 | $1,305 |
| Cyclobenzaprine Hcl | 88 | $1,056 |
| Celecoxib | 62 | $894 |
| Carisoprodol | 18 | $437 |
| Tizanidine Hcl | 55 | $409 |
| Methocarbamol | 24 | $408 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Denver
- Gin-Ming HsuDenver$8K
- Yusuke WakeshimaDenver$5K
- Mara Isser SaxDenver$3K
- Usama GhaziDenver$2K
- Drew TrainorGreenwood Village$320K
- William ScelzaEnglewood$16K
- Aakash ThakralGreeley$14K
- Alan WeintraubEnglewood$10K
- Ryan FlowersGreeley$10K
- Kristina BarberParker$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.